Compare OCS & ECVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OCS | ECVT |
|---|---|---|
| Founded | 2003 | 1935 |
| Country | Switzerland | United States |
| Employees | 60 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.6B |
| IPO Year | N/A | 2017 |
| Metric | OCS | ECVT |
|---|---|---|
| Price | $11.76 | $12.93 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 5 |
| Target Price | ★ $42.00 | $14.00 |
| AVG Volume (30 Days) | 938.4K | ★ 1.8M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.04 |
| Revenue | N/A | ★ $723,515,000.00 |
| Revenue This Year | $466.06 | $29.07 |
| Revenue Next Year | $479.73 | $6.71 |
| P/E Ratio | ★ N/A | $327.00 |
| Revenue Growth | N/A | ★ 2.70 |
| 52 Week Low | $11.70 | $7.39 |
| 52 Week High | $34.48 | $15.09 |
| Indicator | OCS | ECVT |
|---|---|---|
| Relative Strength Index (RSI) | 21.61 | 38.02 |
| Support Level | N/A | $12.74 |
| Resistance Level | $21.00 | $15.01 |
| Average True Range (ATR) | 2.26 | 0.40 |
| MACD | -2.18 | -0.16 |
| Stochastic Oscillator | 2.10 | 5.95 |
Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.
Ecovyst Inc is an integrated and provider of materials, specialty catalysts and services. Its products contribute to lower emissions and cleaner air, higher fuel efficiency and cleaner fuels, and key enablers to advance transition to clean energy. The company has one operating segment. The Company's single reportable segment, Ecoservices, derives its revenue through the sale of virgin and regenerated sulfuric acid products and services.